m-PEG8-BBTA is a PEG-based linker featuring a methoxy group on one end and a BBTA (benzothiazole) moiety on the other. Its PEG8 spacer improves solubility, stability, and biocompatibility, making it ideal for biomedical applications such as drug delivery and bioconjugation.
Key Features:
- Methoxy Termination: Provides stability and reduces unwanted interactions in biological systems.
- BBTA Moiety: Enables targeted binding, useful for drug delivery and imaging applications.
- PEG8 Spacer: Increases water solubility, minimizes immunogenicity, and enhances pharmacokinetics.
Applications:
- Drug Delivery: Functions as a linker in prodrugs and ADCs, boosting solubility and stability.
- Bioconjugation: Attaches therapeutic agents, imaging probes, and biomolecules for diagnostics and therapeutics.
How to Use:
- Storage: Keep at -20°C, away from light and moisture, for long-term stability.
- Solubility: Dissolves in organic solvents like DMSO and methanol for chemical reactions.
m-PEG8-BBTA is a versatile tool for pharmaceutical and biomedical research, supporting the development of advanced therapies and diagnostic technologies.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.